Trial
NCT04849377
RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
—
Condition
Human Papillomavirus (HPV)
Intervention
RT 50 Gy
Why stopped
lack of eligible participants due to change in study criterias
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-07-07